previous compound ID: 783 next compound
InChIKey: GZENKSODFLBBHQ-ILSZZQPISA-N
SMILES: C[C@H]1C[C@H]2[C@@H]3CC[C@@H]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)C(=O)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "GW Carlile" "D Rotin" "DY Thomas" "J Goepp" "SD Macknight" "E Matthes" "B Kus" "R Robert" "JW Hanrahan"

chemical graph of compound 783





CID is 247839
synonyms found at PubChem are:
medrysone, Hydroxymesterone, Medrifar, Medrocort, Medritonic, Visudrisone, 2668-66-8, HMS Liquifilm, 6alpha-Methyl-11beta-hydroxyprogesterone, U-8471, UNII-D2UFC189XF, Medrysone (USAN), GSH 1043, NSC-63278, D2UFC189XF, 11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione, Medriabioptal, Sedesterol, Spectramedryn, Medriusar, Medroftal, MLS000028714, HMS, CHEBI:34829, U 8471, Medrisone [DCIT], CPD000058693, SMR000058693, Medrysonum [INN-Latin], Medrisona [INN-Spanish], 11.beta.-Hydroxy-6.alpha.-methylprogesterone, 6.alpha.-Methyl-11.beta.-hydroxyprogesterone, DSSTox_CID_25371, DSSTox_RID_80833, DSSTox_GSID_45371, (6S,8S,9S,10R,11S,13S,14S,17S)-17-acetyl-11-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one, 11beta-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione, 11.beta.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione, Medrysonum, Medrisona, Medrisone, EINECS 220-208-7, NSC 63278, 11beta-Hydroxy-6alpha-methylprogesterone, 6-alpha-Methyl-11-beta-hydroxyprogesterone, Progesterone, 11beta-hydroxy-6alpha-methyl-, 11-beta-Hydroxy-6-alpha-methylpregn-4-ene-3,20-dione, Medrysone [USAN:USP:INN], Prestwick_89, NCGC00016616-01, CAS-2668-66-8, Opera_ID_635, Prestwick0_000743, Prestwick1_000743, Prestwick2_000743, Prestwick3_000743, D04SFH, AC1L6L4H, HMS (TN), SCHEMBL4493, Pregn-4-ene-3,20-dione, 11-beta-hydroxy-6-alpha-methyl-, BSPBio_000726, MLS001076155, MLS002207230, MLS002222162, SPBio_002665, Pregn-4-ene-3,20-dione, 11-hydroxy-6-methyl-, (6alpha,11beta)-, BPBio1_000800, GTPL7086, CHEMBL1201173, DTXSID6045371, 6-Methyl-11-hydroxyprogesterone, BCBcMAP01_000088, MolPort-003-958-619, HMS1570E08, HMS2097E08, HMS2232F13, HMS3259A22, HMS3714E08, HY-B1076, NSC63278, ZINC3977945, Tox21_110526, 2534AH, AKOS024285179, Tox21_110526_1, CCG-220743, CS-4632, DB00253, NC00599, SMP1_000061, NCGC00179460-01, NCGC00179460-03, SAM002564258, ST082266, C14643, D02289, 668M668, C-44121, Progesterone, 11.beta.-hydroxy-6.alpha.-methyl-, SR-01000721900, SR-01000721900-3, BRD-K56515112-001-03-4, BRD-K56515112-001-21-6, Pregn-4-ene-3, 11.beta.-hydroxy-6.alpha.-methyl-, WLN: L E5 B666 OV MUTJ A1 CQ E1 FV1 L1, Medrysone, United States Pharmacopeia (USP) Reference Standard, Pregn-4-ene-3, 11-hydroxy-6-methyl-, (6.alpha.,11.beta.)-, Pregn-4-ene-3,20-dione, 11beta-hydroxy-6alpha-methyl- (8CI), (1S,2R,8S,10S,11S,14S,15S,17S)-14-acetyl-17-hydroxy-2,8,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one, (1S,8S,10S,11S,14S,15S,17S,2R)-14-acetyl-17-hydroxy-2,8,15-trimethyl-5-oxotetr acyclo[8.7.0.0<2,7>.0<11,15>]heptadec-6-ene